Medicine Man Technologies Stock Fundamentals

SHWZ Stock  USD 0.11  0.00  0.00%   
Medicine Man Technologies fundamentals help investors to digest information that contributes to Medicine Man's financial success or failures. It also enables traders to predict the movement of Medicine Pink Sheet. The fundamental analysis module provides a way to measure Medicine Man's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicine Man pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Medicine Man Technologies Company Return On Equity Analysis

Medicine Man's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Medicine Man Return On Equity

    
  0.16  
Most of Medicine Man's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicine Man Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Medicine Man Technologies has a Return On Equity of 0.1569. This is 100.65% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 150.61% lower than that of the firm.

Medicine Man Technologies Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medicine Man's current stock value. Our valuation model uses many indicators to compare Medicine Man value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicine Man competition to find correlations between indicators driving Medicine Man's intrinsic value. More Info.
Medicine Man Technologies is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.29  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicine Man Technologies is roughly  3.47 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medicine Man by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medicine Man's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Medicine Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicine Man's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medicine Man could also be used in its relative valuation, which is a method of valuing Medicine Man by comparing valuation metrics of similar companies.
Medicine Man is currently under evaluation in return on equity category among its peers.

Medicine Fundamentals

About Medicine Man Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medicine Man Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicine Man using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicine Man Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. The company was incorporated in 2014 and is headquartered in Denver, Colorado. Medicine Man operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 389 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medicine Pink Sheet Analysis

When running Medicine Man's price analysis, check to measure Medicine Man's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicine Man is operating at the current time. Most of Medicine Man's value examination focuses on studying past and present price action to predict the probability of Medicine Man's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicine Man's price. Additionally, you may evaluate how the addition of Medicine Man to your portfolios can decrease your overall portfolio volatility.